TG Therapeutics
TGTX
TGTX
46 hedge funds and large institutions have $33.6M invested in TG Therapeutics in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+10
Holders Change %
+27.78%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
18
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BM
1
Bridger Management
New York
|
$7.56M |
| 2 |
2
Jennison Associates
New York
|
$7.83M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$3.02M |
| 4 |
RCM
4
RA Capital Management
Boston,
Massachusetts
|
$3.02M |
| 5 |
SM
5
Sabby Management
Miami Beach,
Florida
|
$1.4M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$0 |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
NI
4
Numeric Investors
Boston,
Massachusetts
|
$0 |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$40K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
JPMorgan Chase & Co
New York
| – | -$73K | -11,491 | Closed |
|
|
SFPIA
52
Stevens First Principles Investment Advisors
Newport Beach,
California
| – | -$6K | -1,000 | Closed |
|